|
|
 |
 |
| Proteins Congress 2010 is administered by Osney Media. |
|
|
|
|
 Speakers |
|
|
|
|
Our carefully researched speaker programmes are further enhanced by the opportunity for the delegates and speakers to discuss topics of interest in more detail during panel discussions. This means that the attendees not only benefit from the expertise of the high level speaker panel but also that of the other delegates.
If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Antje Girndt at a.girndt@oxfordglobal.co.uk
The conference agenda was formulated with the help of an advisory panel which consisted of the experts below.
The 2010 Advisory Panel includes:
- Imre Berger, Group Leader Structural complexomics of eukaryotic gene expression, EMBL, Grenoble, France
- Nicola Burgess Brown, Head of Biotechnology at SGC (The Structural Genomics Consortium), University of Oxford
- Diego Rodriguez Cabaleiro, BioPharmaceutical Business Development Manager, Chemistry Operations, Waters European Headquarters
- Naomi Chayen, President of the International Organisation for Biological Crystallization, Department of BioMolecular Medicine, SORA Division, Faculty of Medicine, Imperial College London
- Ciaran N. Cronin, Head of Parallel Protein Production Group, Pfizer La Jolla
- Michael Dyson, Senior Research Associate, Department of Biochemistry, University of Cambridge
- Christian Heinis, Group Head, Laboratory of Therapeutic Peptides and Proteins, Ecole Polytechnique Federal de Lausanne (EPFL)
- Stephen Irving, Senior Principal Scientist, Pfizer
- Syd Johnson, Vice President, Antibody Engineering, MacroGenics
- Gerhardus de Jong, Biomedical Analysis, Dept. of Pharmaceutical Sciences, Faculty of Science, Utrecht University
- Uday Kishore, Director Centre for Infection, Immunity and Disease Mechanisms, Brunel University
- Karol Kozak, LMC RISC, Head of Computational Analysis RISC, ETH Zurich
- Tomas Lundqvist, Director CPSS Sweden at Astrazeneca, AstraZeneca
- Sigurd Okkels, Vice President, Department of Biologics at Nycomed GmbH
- Pier Giorgio Righetti, Professor, Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano
- Aaron Sato, Senior Director of Antibody Engineering, OncoMed Pharmaceuticals
- Frank Schaefer, Associate Director R&D / Protein Sciences at QIAGEN GmbH
- Arne Skerra, Professor of Biological Chemistry, Technische Universitaet Muenchen, Freising-Weihenstephan, Germany
- David E. Szymkowski, Senior Director, Biotherapeutics Xencor, Inc.
- Peter Sondermann, CSO at SuppreMol GmbH
- Barbara Valsasina, Senior Scientist, Biology Department, Nerviano Medical Sciences
- Paul Watt, Executive Director, CSO and VP of Corporate Development, Phylogica
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dan Bach-Kristensen, Senior Pharmaceutical Scientist, Nycomed, Denmark
|
|
|
|
Hans Baumeister, COO Glycotope GmbH
|
|
|
|
Jacques Bellalou, Head of Platform for recombinant protein production in microorganisms, Structural Biology and Chemistry Department, Institut Pasteur, France
|
|
|
|
Claudio Belluco, Senior Scientist, CRO - IRCCS, National Cancer Institute, Aviano
|
|
|
|
Lorenzo Benatuil, Senior Scientist, Biologics Abbott Bioresearch Center, USA
|
|
|
|
Berthold Boedeker, Head of Cell Culture and Pilot Plants, Global Drug Discovery & Biotech Development Bayer Schering Pharma AG
|
|
|
|
Anne Bondgaard Tolstrup, Director, Antibody Expression, Symphogen A/S
|
|
|
|
Christophe Bonny, CEO, Xigen, Switzerland
|
|
|
|
Roland Brock, Chair, Biochemistry of Integrated Systems; Head, Department of Biochemistry, Nijmegen Centre for Molecular Life Sciences, Radboud University
|
|
|
|
Konrad Buessow, Team Leader, Division of Structural Biology, Helmholtz Centre for Infection Research
|
|
|
|
Robin Butler, Senior R&D Manager, Protein Science MedImmune
|
|
|
|
Stefan Dübel, Professor of Biotechnology, Technische Universitaet Braunschweig, Germany
|
|
|
|
Rainer Fischer, Senior Executive Director, Fraunhofer-Institute for Molecular Biology and Applied Ecology IME-MB, Germany
|
|
|
|
Darren Hart, Team Leader, EMBL, Grenoble
|
|
|
|
Judith Hartleib, Group Leader, AstraZeneca
|
|
|
|
Bernhard Helk, Section Head Technology Development Novartis Pharma AG, Basel
|
|
|
|
Stephen Irving, Senior Principal Scientist, Pfizer Global Research & Development
|
|
|
|
Thomas Jostock, Technology/Platform Leader, Novartis Leading Scientist
|
|
|
|
Ulrike Korf, Head of Molecular Genome Analysis Department, DKFZ (German Cancer Research Centre
|
|
|
|
Debbie Law, CSO, Ablynx
|
|
|
|
Melvyn Little, CSO, Affimed Therapeutics AG, Germany
|
|
|
|
Ton Logtenberg, CEO Merus
|
|
|
|
Paolo Martini, Director, Protein Expressions and Purification Research, Shire Human Genetic Therapies
|
|
|
|
Judit Nagy, Director of Proteomics Facility, Imperial College London
|
|
|
|
Jo Nettleship, Senior Scientist OPPF-UK, Research Complex at Harwell, Oxford
|
|
|
|
Malak K. Pirtskhalava, Head of the Department of Structural Bioinformatics, Institute of Molecular Biology and Biophysics, Tbilisi State University
|
|
|
|
Andreas Plückthun, Professor of Biochemistry, University of Zurich
|
|
|
|
Rick Rutter, Vice President of Pharmaceutical Sciences Global Biologics, Pfizer
|
|
|
|
Irina Rybina, Senior Scientist Group Leader Gene to Protein, High-throughput Biology, Boehringer Ingelheim Pharmaceuticals, Inc. USA
|
|
|
|
Herwig Schüler, Team Leader, Structural Genomics Consortium, Karolinkska Institutet, Stockholm
|
|
|
|
Manfred Schuster, COO, APEIRON Biologics AG, Vienna, Austria
|
|
|
|
Arne Skerra, Professor of Biological Chemistry, Technische Universitaet Muenchen, Freising-Weihenstephan, Germany & Founder and CEO, XL-protein GmbH
|
|
|
|
Young-Hwa Song, Head of moleulcar Biol & Biochem Lab, EMBL-Hamburg, Germany
|
|
|
|
Willem 'Pim' Stemmer, CEO, Amunix Inc.
|
|
|
|
Michael Sundstrom, Managing Director NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen
|
|
|
|
Yvonne Thielmann, Research Scientist, Department of Molecular Membrane Biology, Max Planck Institute for Biophysics
|
|
|
|
Barbara Valsasina, Senior Scientist, Biology Department, Nerviano Medical Sciences
|
|
|
|
Jan van de Winkel, President Research & Development and Chief Scientific Officer, GenMab A/S
|
|
|
|
Dmitry Veprintsev, Senior Scientist, Paul Scherrer Institute, Switzerland
|
|
|
|
Peter Vorstheim, Senior Vice President, BU HESylation® Technology; Kabi Innovation Centre, Fresenius Kabi Deutschland GmbH
|
|
|
|
Paul Watt, CSO & CEO Phylogica
|
|
|
|
Florian Wurm, Professor of Biotechnology, Laboratory of Cellular Biotechnology, EPFL; Founder and CSO, ExcellGene SA, Switzerland
|
|
|
|
Zhenping Zhu, Vice President and Global Head, Protein Sciences and Design, Novartis
|
|
|
|
Eugene Zhukovsky, Senior Research Fellow, Boehringer Ingelheim
|
|
|
|
|
|
|
|
|
|
|
